New WHO Europe action plan to fight MDR-TB.
ثبت نشده
چکیده
As the multidrugand extensively drug-resistant tuberculosis (M/XDR-TB) is spreading at alarming rates in the World Health Organization (WHO) European Region – about 81,000 (18.4%) of the estimated 440,000 patients worldwide with MDR-TB are considered to live in this region – the WHO Regional Office for Europe has launched an action plan to contain the spread of drugresistant TB in the region by the end of 2015 [1,2]. This action plan was endorsed on 15 September 2011 by all 53 countries of the WHO European Region [3].
منابع مشابه
A framework action plan to fight tuberculosis in the European Union.
Framework Action Plan to fight tuberculosis in the European Union 2 PREFACE The European Union's (EU) Health Commissioner, Markos Kyprianou, called on the European Centre for Disease Prevention and Control (ECDC) in March 2007 to develop a proposal for an action plan to fight tuberculosis (TB) in the EU 1. This initiative reflects the priority given to TB in the EU where this disease is a conti...
متن کاملMultidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research.
Globally, tuberculosis (TB) is one of the leading causes of death due to an infectious disease, second only to HIV/AIDS [1, 2]. Estimates suggest that approximately one-third of the world’s population is infected with Mycobacterium tuberculosis, the microbe that causes TB, and 10% of infected individuals will develop active TB at some point in their lives. For individuals also infected with HIV...
متن کاملSPECIAL REPORT Progressing towards TB elimination A follow-up to the Framework Action Plan to Fight Tuberculosis in the European Union
The plan was developed by the disease-specific programme for TB, following a request from the EuropeanCommission. We would like to acknowledge the following for contributing to and commenting on the report: The Advisory Forum, European Reference Laboratory Network for TB (ERLN-TB), TB surveillance contact points, Wolfeheze/WHO NTP Managers forum, Civil society participants to 2009 EU–Commission...
متن کاملFinal treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens.
Latvia is a high-priority country in the fight against tuberculosis (TB) in Europe, with an estimated TB incidence of 41 per 100000 in 2015 [1]. In spite of an improving TB control programme [2] and cure rates reaching 80% for new and retreatment TB cases notified in 2014, multidrug-resistant (MDR-) TB (defined as TB resistant to rifampicin and isoniazid) rates in Latvia remain high [1]. An est...
متن کاملEnding the Global Tuberculosis Epidemic by 2030 - The Moscow Declaration and achieving a Major Translational Change in Delivery of TB Healthcare.
According to the latest WHO Annual Global TB Report (WHO, 2017a), Tuberculosis (TB) remains the world’s top infectious diseases cause of death, being responsible for an estimated 1.674.000 deaths worldwide in 2016. Alarmingly, there were 600.000 cases of rifampicin-resistant TB of which 490.000 had multidrug-resistant TB (MDR-TB). Less than 50% of these patients survive after receiving currentl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
دوره 16 37 شماره
صفحات -
تاریخ انتشار 2011